BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27535357)

  • 1. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
    Lord E; Stockdale AJ; Malek R; Rae C; Sperle I; Raben D; Freedman A; Churchill D; Lundgren J; Sullivan AK;
    HIV Med; 2017 Apr; 18(4):300-304. PubMed ID: 27535357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of HIV testing recommendations in Greek specialty guidelines: A missed opportunity and room for improvement for recommending testing.
    Akinosoglou K; Kostaki EG; Paraskevis D; Gogos CA
    AIDS Care; 2021 Oct; 33(10):1312-1315. PubMed ID: 33678071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of HIV testing recommendations in Australian specialty guidelines for HIV indicator conditions: a missed opportunity for recommending testing?
    Lin YD; Eades L; Nair A; Korman TM; Woolley I
    Intern Med J; 2020 Mar; 50(3):293-298. PubMed ID: 31566841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
    Jordans CCE; Vasylyev M; Rae C; Jakobsen ML; Vassilenko A; Dauby N; Grevsen AL; Jakobsen SF; Raahauge A; Champenois K; Papot E; Malin JJ; Boender TS; Behrens GMN; Gruell H; Neumann A; Spinner CD; Valbert F; Akinosoglou K; Kostaki EG; Nozza S; Giacomelli A; Lapadula G; Mazzitelli M; Torti C; Matulionyte R; Matulyte E; Van Welzen BJ; Hensley KS; Thompson M; Ankiersztejn-Bartczak M; Skrzat-Klapaczyńska A; Săndulescu O; Streinu-Cercel A; Streinu-Cercel A; Miron VD; Pokrovskaya A; Hachfeld A; Dorokhina A; Sukach M; Lord E; Sullivan AK; Rokx C;
    Euro Surveill; 2022 Dec; 27(48):. PubMed ID: 36695464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
    Raben D; Mocroft A; Rayment M; Mitsura VM; Hadziosmanovic V; Sthoeger ZM; Palfreeman A; Morris S; Kutsyna G; Vassilenko A; Minton J; Necsoi C; Estrada VP; Grzeszczuk A; Johansson VS; Begovac J; Ong EL; Cabié A; Ajana F; Celesia BM; Maltez F; Kitchen M; Comi L; Dragsted UB; Clumeck N; Gatell J; Gazzard B; d'Arminio Monforte A; Rockstroh J; Yazdanpanah Y; Champenois K; Jakobsen ML; Sullivan A; Lundgren JD;
    PLoS One; 2015; 10(11):e0140845. PubMed ID: 26560105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General practitioners' barriers and facilitators towards new provider-initiated HIV testing strategies: a qualitative study.
    Joore IK; van Roosmalen SL; van Bergen JE; van Dijk N
    Int J STD AIDS; 2017 Apr; 28(5):459-466. PubMed ID: 27207253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study.
    Bogers SJ; Schim van der Loeff MF; Davidovich U; Boyd A; van der Valk M; Brinkman K; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
    BMC Infect Dis; 2021 Jun; 21(1):519. PubMed ID: 34078315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2014 European Guideline on HIV testing.
    Gökengin D; Geretti AM; Begovac J; Palfreeman A; Stevanovic M; Tarasenko O; Radcliffe K
    Int J STD AIDS; 2014 Sep; 25(10):695-704. PubMed ID: 24759563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.
    Raben D; Sullivan AK; Mocroft A; Kutsyna G; Hadžiosmanović V; Vassilenko A; Chkhartisvili N; Mitsura V; Pedersen C; Anderson J; Begovac J; Bak Dragsted U; Bertisch B; Grzeszczuk A; Minton J; Necsoi VC; Kitchen M; Ajana F; Sokhan A; Comi L; Farazmand P; Pesut D; De Wit S; Gatell JM; Gazzard B; d'Arminio Monforte A; Rockstroh JK; Yazdanpanah Y; Champenois K; Jakobsen ML; Lundgren JD;
    PLoS One; 2019; 14(8):e0220108. PubMed ID: 31408476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of HIV test results, post-test discussion and referral in health care settings: a review of guidance for European countries.
    Bell SA; Delpech V; Casabona J; Tsereteli N; de Wit J
    HIV Med; 2015 Nov; 16(10):620-7. PubMed ID: 26108859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions.
    Menacho I; Sequeira E; Muns M; Barba O; Leal L; Clusa T; Fernandez E; Moreno L; Raben D; Lundgren J; Gatell JM; Garcia F; Cayuelas L; Aragunde V; Vergara M; Catalan M; Moreno MA; Hormigo G; Siso A; Herreras Z; Sebastian L; Benito L; Picas A; Hoyo J; Giner MJ; Cararach D; Moles E; Moro ML; Arrabal P; Roca D; Prego S; Ferrer X; Egido A; Ventosa C; Garcia S; Muñoz S; Massana A; Sole J; Curiel M; Heras F; Leon A
    HIV Med; 2013 Oct; 14 Suppl 3():33-7. PubMed ID: 24033901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of HIV care in the UK: results of British HIV association (BHIVA) national audit 2010.
    Ellis S; Curtis H; Ong E;
    Int J STD AIDS; 2013 Apr; 24(4):329-31. PubMed ID: 23970666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care.
    Joore IK; Twisk DE; Vanrolleghem AM; de Ridder M; Geerlings SE; van Bergen JE; van den Broek IV
    BMC Fam Pract; 2016 Nov; 17(1):161. PubMed ID: 27855639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV pre-test information, discussion or counselling? A review of guidance relevant to the WHO European Region.
    Bell SA; Delpech V; Raben D; Casabona J; Tsereteli N; de Wit J
    Int J STD AIDS; 2016 Feb; 27(2):97-104. PubMed ID: 25941051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV testing in patients presenting with indicator conditions in outpatient settings: offer and uptake rates, and educational and active interventions.
    Youssef E; Sanghera T; Bexley A; Hayes M; Perry N; Dosekun O; Perera S
    Int J STD AIDS; 2018 Nov; 29(13):1289-1294. PubMed ID: 29979144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV testing in dermatology - a national audit.
    Esson GA; Holme SA
    Int J STD AIDS; 2018 May; 29(6):611-613. PubMed ID: 28950765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of new national HIV testing guidelines at a district general hospital in an area of high HIV seroprevalence.
    Page I; Phillips M; Flegg P; Palmer R
    J R Coll Physicians Edinb; 2011 Mar; 41(1):9-12. PubMed ID: 21365059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to targeted HIV testing on an acute admissions unit: evaluation of the UK guideline.
    Peck L; Ferenczi E; Burns F; Cosgrove C; Brown M
    QJM; 2010 Mar; 103(3):147-51. PubMed ID: 20040534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
    Orkin C; Flanagan S; Wallis E; Ireland G; Dhairyawan R; Fox J; Nandwani R; O'Connell R; Lascar M; Bulman J; Reeves I; Palfreeman A; Foster GR; Ahmad K; Anderson J; Tong CY; Lattimore S
    HIV Med; 2016 Mar; 17(3):222-30. PubMed ID: 26919291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV testing in Lanarkshire.
    Acquah RR; Baggott A; McGoldrick C; Kennedy N
    J R Coll Physicians Edinb; 2014; 44(4):278-82. PubMed ID: 25516895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.